PHENOBARBITAL SODIUM MSDS - AN OVERVIEW

Contraindicated (one)pentobarbital will minimize the extent or effect of lumefantrine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with sturdy CYP3A4 inducers may result in lowered serum concentrations and loss of antimalarial efficacypentobarbital will decrease the level or effect of mavacamten by imp